Impact of polymorphisms in the DC-SIGNR neck domain on the interaction with pathogens (Q40488621)

21 September 2017

title

Impact of polymorphisms in the DC-SIGNR neck domain on the interaction with pathogens (English)

1 reference

21 September 2017

5

1 reference

21 September 2017

Andrea Marzi

4

0 references

Stefan Pöhlmann

object named as

Stefan Pöhlmann

9

0 references

author name string

Thomas Gramberg

1

1 reference

21 September 2017

Tuofu Zhu

2

1 reference

21 September 2017

Chawaree Chaipan

3

1 reference

21 September 2017

Anja Wegele

6

1 reference

21 September 2017

Thomas Andrus

7

1 reference

21 September 2017

Heike Hofmann

8

1 reference

21 September 2017

language of work or name

English

0 references

publication date

18 January 2006

1 reference

21 September 2017

1 reference

21 September 2017

volume

347

1 reference

21 September 2017

issue

2

1 reference

21 September 2017

page(s)

354-363

1 reference

C-type lectins DC-SIGN and L-SIGN mediate cellular entry by Ebola virus in cis and in trans

21 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.033

Functional and antigenic characterization of human, rhesus macaque, pigtailed macaque, and murine DC-SIGN.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.033

The role of DC-SIGN and DC-SIGNR in HIV and Ebola virus infection: can potential therapeutics block virus transmission and dissemination?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.033

Quantitative expression and virus transmission analysis of DC-SIGN on monocyte-derived dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.033

A dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin (DC-SIGN)-related protein is highly expressed on human liver sinusoidal endothelial cells and promotes HIV-1 infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.033

Proteomic analysis of DC-SIGN on dendritic cells detects tetramers required for ligand binding but no association with CD4.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.033

Cell surface heparan sulfate is a receptor for human herpesvirus 8 and interacts with envelope glycoprotein K8.1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.033

Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.033

L-SIGN (CD209L) and DC-SIGN (CD209) mediate transinfection of liver cells by hepatitis C virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.033

The dendritic cell-specific adhesion receptor DC-SIGN internalizes antigen for presentation to T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.033

Structural basis for selective recognition of oligosaccharides by DC-SIGN and DC-SIGNR

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.033

Extended neck regions stabilize tetramers of the receptors DC-SIGN and DC-SIGNR.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.033

L-SIGN (CD 209L) is a liver-specific capture receptor for hepatitis C virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.033

DC-SIGN-ICAM-2 interaction mediates dendritic cell trafficking.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.033

DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.033

Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.033

Pathogenesis of Ebola hemorrhagic fever in cynomolgus macaques: evidence that dendritic cells are early and sustained targets of infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.033

Pathogenesis of Ebola hemorrhagic fever in primate models: evidence that hemorrhage is not a direct effect of virus-induced cytolysis of endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.033

Dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin/CD209 is abundant on macrophages in the normal human lymph node and is not required for dendritic cell stimulation of the mixed leukocyte reaction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.033

Structural basis for distinct ligand-binding and targeting properties of the receptors DC-SIGN and DC-SIGNR.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.033

S protein of severe acute respiratory syndrome-associated coronavirus mediates entry into hepatoma cell lines and is targeted by neutralizing antibodies in infected patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.033

Human coronavirus NL63 employs the severe acute respiratory syndrome coronavirus receptor for cellular entry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.033

Increased mucosal transmission but not enhanced pathogenicity of the CCR5-tropic, simian AIDS-inducing simian/human immunodeficiency virus SHIV(SF162P3) maps to envelope gp120.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.033

Expression of DC-SIGN by dendritic cells of intestinal and genital mucosae in humans and rhesus macaques

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.033

Distinct functions of DC-SIGN and its homologues L-SIGN (DC-SIGNR) and mSIGNR1 in pathogen recognition and immune regulation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.033

The tandem-repeat polymorphism of the DC-SIGNR gene does not affect the susceptibility to HIV infection and the progression to AIDS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.033

Analysis of genetic polymorphisms in CCR5, CCR2, stromal cell-derived factor-1, RANTES, and dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin in seronegative individuals repeatedly exposed to HIV-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.033

Most DC-SIGNR transcripts at mucosal HIV transmission sites are alternatively spliced isoforms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.033

DC-SIGN and L-SIGN are high affinity binding receptors for hepatitis C virus glycoprotein E2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.033

C-type lectins L-SIGN and DC-SIGN capture and transmit infectious hepatitis C virus pseudotype particles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.033

Hepatitis C virus targets DC-SIGN and L-SIGN to escape lysosomal degradation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.033

Association of DC-SIGN promoter polymorphism with increased risk for parenteral, but not mucosal, acquisition of human immunodeficiency virus type 1 infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.033

DC-SIGN and DC-SIGNR interact with the glycoprotein of Marburg virus and the S protein of severe acute respiratory syndrome coronavirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.033

A novel mechanism of carbohydrate recognition by the C-type lectins DC-SIGN and DC-SIGNR. Subunit organization and binding to multivalent ligands

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.033

DC-SIGN promotes exogenous MHC-I-restricted HIV-1 antigen presentation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.033

Extensive repertoire of membrane-bound and soluble dendritic cell-specific ICAM-3-grabbing nonintegrin 1 (DC-SIGN1) and DC-SIGN2 isoforms. Inter-individual variation in expression of DC-SIGN transcripts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.033

DC-SIGN interactions with human immunodeficiency virus type 1 and 2 and simian immunodeficiency virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.033

DC-SIGN interactions with human immunodeficiency virus: virus binding and transfer are dissociable functions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.033

DC-SIGNR, a DC-SIGN homologue expressed in endothelial cells, binds to human and simian immunodeficiency viruses and activates infection in trans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.033

Hepatitis C virus glycoproteins interact with DC-SIGN and DC-SIGNR

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.033

A variant in the CD209 promoter is associated with severity of dengue disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.033

DC-SIGN and DC-SIGNR bind ebola glycoproteins and enhance infection of macrophages and endothelial cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.033

The Structure of DC-SIGNR with a Portion of its Repeat Domain Lends Insights to Modeling of the Receptor Tetramer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.033

Characterization of DC-SIGN/R interaction with human immunodeficiency virus type 1 gp120 and ICAM molecules favors the receptor's role as an antigen-capturing rather than an adhesion receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.033

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.033

Placental expression of DC-SIGN may mediate intrauterine vertical transmission of HIV

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.033

Expression of human immunodeficiency virus (HIV)-binding lectin DC-SIGNR: Consequences for HIV infection and immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.033

Primary cultures of endothelial cells from the human liver sinusoid are permissive for human immunodeficiency virus type 1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.033

DC-SIGN: escape mechanism for pathogens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.033

pH-dependent entry of severe acute respiratory syndrome coronavirus is mediated by the spike glycoprotein and enhanced by dendritic cell transfer through DC-SIGN

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.033

Constitutive and induced expression of DC-SIGN on dendritic cell and macrophage subpopulations in situ and in vitro

7 January 2021

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/16413044

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1016/J.VIROL.2005.11.033

1 reference

21 September 2017

1 reference